FMT Delivered by Capsule Versus Colonoscopy for Recurrent C. Diff
A Prospective, Multi-center, Randomized Trial of Fecal Microbiota Transplantation (FMT) Delivered by Capsule vs Colonoscopy in the Management of Recurrent Clostridium Difficile Infection (CDI)
Sponsor: University of Alberta
Listed as NCT02254811, this PHASE2/PHASE3 trial focuses on Enterocolitis Clostridium Difficile Recurrent and remains completed. Sponsored by University of Alberta, it has been updated 8 times since 2014, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE2/PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2/PHASE3
Phase: PHASE2_PHASE3 → PHASE2/PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE2_PHASE3
-
Nov 2019 — Jan 2021 [monthly]
Completed PHASE2_PHASE3
Status: Active Not Recruiting → Completed
-
Jul 2018 — Nov 2019 [monthly]
Active Not Recruiting PHASE2_PHASE3
▶ Show 3 earlier versions
-
Jun 2018 — Jul 2018 [monthly]
Active Not Recruiting PHASE2_PHASE3
-
Feb 2017 — Jun 2018 [monthly]
Active Not Recruiting PHASE2_PHASE3
-
Jan 2017 — Feb 2017 [monthly]
Active Not Recruiting PHASE2_PHASE3
First recorded
Sep 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University of Alberta
- University of Calgary
For direct contact, visit the study record on ClinicalTrials.gov .